Cinclus' severe erosive GERD candidate well tolerated in Phase I

Cinclus Pharma AG (Basel, Switzerland) said single and multiple ascending doses

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE